Two Sigma Securities LLC Cuts Stock Position in Plexus Corp. $PLXS

Two Sigma Securities LLC decreased its holdings in shares of Plexus Corp. (NASDAQ:PLXS) by 64.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,430 shares of the technology company’s stock after selling 2,614 shares during the period. Two Sigma Securities LLC’s holdings in Plexus were worth $430,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Plexus in the 2nd quarter worth $32,000. Kilter Group LLC purchased a new position in Plexus during the second quarter valued at $40,000. Persistent Asset Partners Ltd acquired a new stake in shares of Plexus in the second quarter valued at about $71,000. Covestor Ltd grew its position in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after purchasing an additional 162 shares during the period. Finally, Caitlin John LLC purchased a new stake in shares of Plexus during the second quarter worth about $74,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Stock Up 0.3%

Shares of NASDAQ PLXS opened at $239.29 on Thursday. The stock has a market cap of $6.40 billion, a PE ratio of 35.29 and a beta of 0.89. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 12-month low of $132.03 and a 12-month high of $307.06. The company has a 50-day moving average of $260.39 and a 200 day moving average of $244.98.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The business’s revenue was up 28.2% on a year-over-year basis. During the same period last year, the company posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, sell-side analysts predict that Plexus Corp. will post 7.11 EPS for the current fiscal year.

Insider Buying and Selling

In other Plexus news, insider Michael J. Running sold 510 shares of the company’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the sale, the insider directly owned 665 shares in the company, valued at $180,993.05. This represents a 43.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the sale, the director owned 7,535 shares of the company’s stock, valued at approximately $1,814,955.45. The trade was a 6.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 8,010 shares of company stock worth $2,178,182 in the last three months. Company insiders own 1.78% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PLXS. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research note on Friday, July 31st. Needham & Company LLC reiterated a “buy” rating and set a $310.00 price objective on shares of Plexus in a research note on Friday, August 14th. Weiss Ratings cut Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, August 11th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Finally, Stifel Nicolaus lifted their price target on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $273.00.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.